412 related articles for article (PubMed ID: 34360919)
1. Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer.
Taneja S; Vetter SW; Leclerc E
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360919
[TBL] [Abstract][Full Text] [Related]
2. Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis.
Leung SS; Forbes JM; Borg DJ
Curr Diab Rep; 2016 Oct; 16(10):100. PubMed ID: 27612847
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia driven glycation: Mechanisms and therapeutic opportunities.
Khan MI; Rath S; Adhami VM; Mukhtar H
Semin Cancer Biol; 2018 Apr; 49():75-82. PubMed ID: 28546110
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia.
Pichiule P; Chavez JC; Schmidt AM; Vannucci SJ
J Biol Chem; 2007 Dec; 282(50):36330-40. PubMed ID: 17942394
[TBL] [Abstract][Full Text] [Related]
5. The RAGE/multiligand axis: a new actor in tumor biology.
Rojas A; Schneider I; Lindner C; Gonzalez I; Morales MA
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35727208
[TBL] [Abstract][Full Text] [Related]
6. Glycation reaction and the role of the receptor for advanced glycation end-products in immunity and social behavior.
Leerach N; Harashima A; Munesue S; Kimura K; Oshima Y; Goto H; Yamamoto H; Higashida H; Yamamoto Y
Glycoconj J; 2021 Jun; 38(3):303-310. PubMed ID: 33108607
[TBL] [Abstract][Full Text] [Related]
7. RAGE Signaling in Melanoma Tumors.
Olaoba OT; Kadasah S; Vetter SW; Leclerc E
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256110
[TBL] [Abstract][Full Text] [Related]
8. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
Riuzzi F; Sorci G; Donato R
J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
[TBL] [Abstract][Full Text] [Related]
9. The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway.
Ren L; Lou Y; Sun M
Bioengineered; 2021 Dec; 12(1):5985-5995. PubMed ID: 34477479
[TBL] [Abstract][Full Text] [Related]
10. AGEs, RAGEs and s-RAGE; friend or foe for cancer.
Ahmad S; Khan H; Siddiqui Z; Khan MY; Rehman S; Shahab U; Godovikova T; Silnikov V; Moinuddin
Semin Cancer Biol; 2018 Apr; 49():44-55. PubMed ID: 28712719
[TBL] [Abstract][Full Text] [Related]
11. Activation of the receptor for advanced glycation end products and consequences on health.
Wautier MP; Guillausseau PJ; Wautier JL
Diabetes Metab Syndr; 2017; 11(4):305-309. PubMed ID: 27612394
[TBL] [Abstract][Full Text] [Related]
12. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation.
Huttunen HJ; Kuja-Panula J; Sorci G; Agneletti AL; Donato R; Rauvala H
J Biol Chem; 2000 Dec; 275(51):40096-105. PubMed ID: 11007787
[TBL] [Abstract][Full Text] [Related]
13. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions.
Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA
Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227
[TBL] [Abstract][Full Text] [Related]
14. Advanced Glycation End Products Affect Osteoblast Proliferation and Function by Modulating Autophagy Via the Receptor of Advanced Glycation End Products/Raf Protein/Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase/Extracellular Signal-regulated Kinase (RAGE/Raf/MEK/ERK) Pathway.
Meng HZ; Zhang WL; Liu F; Yang MW
J Biol Chem; 2015 Nov; 290(47):28189-28199. PubMed ID: 26472922
[TBL] [Abstract][Full Text] [Related]
15. Perspectives on signaling for biological- and processed food-related advanced glycation end-products and its role in cancer progression.
Eva TA; Barua N; Chowdhury MM; Yeasmin S; Rakib A; Islam MR; Emran TB; Simal-Gandara J
Crit Rev Food Sci Nutr; 2022; 62(10):2655-2672. PubMed ID: 33307763
[TBL] [Abstract][Full Text] [Related]
16. Advanced Glycation End Products and Receptor (RAGE) Promote Wound Healing of Human Corneal Epithelial Cells.
Gross C; Belville C; Lavergne M; Choltus H; Jabaudon M; Blondonnet R; Constantin JM; Chiambaretta F; Blanchon L; Sapin V
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):14. PubMed ID: 32176265
[TBL] [Abstract][Full Text] [Related]
17. Ousting RAGE in melanoma: A viable therapeutic target?
Syed DN; Aljohani A; Waseem D; Mukhtar H
Semin Cancer Biol; 2018 Apr; 49():20-28. PubMed ID: 29079306
[TBL] [Abstract][Full Text] [Related]
18. Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation.
Huttunen HJ; Kuja-Panula J; Rauvala H
J Biol Chem; 2002 Oct; 277(41):38635-46. PubMed ID: 12167613
[TBL] [Abstract][Full Text] [Related]
19. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.
Stern DM; Yan SD; Yan SF; Schmidt AM
Ageing Res Rev; 2002 Feb; 1(1):1-15. PubMed ID: 12039445
[TBL] [Abstract][Full Text] [Related]
20. Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system.
Sotokawauchi A; Matsui T; Higashimoto Y; Yamagishi SI
Diab Vasc Dis Res; 2019 Nov; 16(6):556-561. PubMed ID: 31375034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]